HTT and Huntington disease: This model is unique in that it expresses only the human HD gene, heterozygous for the HD mutation (with an expanded CAG of 97 repeats), on a mouse Huntingtin null (Hdh-/-) background [11], and therefore provides a valuable tool to evaluate the efficacy of selective muHTT ASO therapies.